(13S)-3-amino-2-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (13S)-3-amino-2-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
• 化学式: C₁₉H₂₅NO₂
• 分子量: 299.4
• InChiKey: FHMCZPRVDFBWPZ-JEYHISOSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  22
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.63
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Estradiol derivatives
  申请人：Agoston E. Gregory

  公开号：US20070135400A1

  公开（公告）日：2007-06-14

  Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering compounds of the general formula: wherein the variables are defined in the specification.

  本发明提供了一种通过给予下述通式化合物治疗恶性血管生成的哺乳动物疾病的组合物和方法：其中变量在规范中定义。
• Methods of treating disease states using antiangiogenic agents
  申请人：Agoston E. Gregory

  公开号：US20070010505A1

  公开（公告）日：2007-01-11

  Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering compounds of the general formula: wherein the variables are defined in the specification.

  通过给予一般公式中的化合物治疗由不良血管生成特征的哺乳动物疾病的组合物和方法：其中变量在规范中定义。
• METHOD OF TREATING AMYLOIDOSIS MEDIATED DISEASES
  申请人：LaVallee Theresa M.

  公开号：US20080234243A1

  公开（公告）日：2008-09-25

  The compounds of the present invention can be used to inhibit formation of beta-amyloid protein. The present invention provides methods of preventing, delaying onset of, or treating diseases or conditions characterized or mediated by amyloidosis. In particular, the present invention is useful for preventing, delaying onset of, and treating Alzheimer's disease and related diseases causing dementia.
• US7371741B2
  申请人：——

  公开号：US7371741B2

  公开（公告）日：2008-05-13
• US7342004B2
  申请人：——

  公开号：US7342004B2

  公开（公告）日：2008-03-11